463 related articles for article (PubMed ID: 27140635)
1. Aquaporin gene therapy corrects Sjögren's syndrome phenotype in mice.
Lai Z; Yin H; Cabrera-Pérez J; Guimaro MC; Afione S; Michael DG; Glenton P; Patel A; Swaim WD; Zheng C; Nguyen CQ; Nyberg F; Chiorini JA
Proc Natl Acad Sci U S A; 2016 May; 113(20):5694-9. PubMed ID: 27140635
[TBL] [Abstract][Full Text] [Related]
2. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
3. Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Yin H; Cabrera-Perez J; Lai Z; Michael D; Weller M; Swaim WD; Liu X; Catalán MA; Rocha EM; Ismail N; Afione S; Rana NA; Di Pasquale G; Alevizos I; Ambudkar I; Illei GG; Chiorini JA
Arthritis Rheum; 2013 Dec; 65(12):3228-38. PubMed ID: 23982860
[TBL] [Abstract][Full Text] [Related]
4. Involvement of aquaporin 5 in Sjögren's syndrome.
Chivasso C; D'Agostino C; Parisis D; Soyfoo MS; Delporte C
Autoimmun Rev; 2023 Mar; 22(3):103268. PubMed ID: 36621535
[TBL] [Abstract][Full Text] [Related]
5. Subcellular distribution of aquaporin 5 in salivary glands in primary Sjögren's syndrome.
Beroukas D; Hiscock J; Jonsson R; Waterman SA; Gordon TP
Lancet; 2001 Dec; 358(9296):1875-6. PubMed ID: 11741631
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
7. Expression of aquaporin 3 and 5 as a potential marker for distinguishing dry mouth from Sjögren's syndrome.
Ichiyama T; Nakatani E; Tatsumi K; Hideshima K; Urano T; Nariai Y; Sekine J
J Oral Sci; 2018; 60(2):212-220. PubMed ID: 29925705
[TBL] [Abstract][Full Text] [Related]
8. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
Yin H; Nguyen CQ; Samuni Y; Uede T; Peck AB; Chiorini JA
Arthritis Res Ther; 2012 Feb; 14(1):R40. PubMed ID: 22369699
[TBL] [Abstract][Full Text] [Related]
9. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
10. Gene therapeutics in Sjögren's syndrome.
Bolstad AI; Jonsson R
Expert Opin Biol Ther; 2005 Jun; 5(6):763-72. PubMed ID: 15952907
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
12. Downregulated GPX4 in salivary gland epithelial cells contributes to salivary secretion dysfunction in Sjogren's syndrome via lipid ROS/pSTAT4/AQP5 axis.
Zhou J; Pathak JL; Wu L; Chen B; Cao T; Wei W; Wu X; Chen G; Watanabe N; Li X; Li J
Free Radic Biol Med; 2024 Jun; 218():1-15. PubMed ID: 38574973
[TBL] [Abstract][Full Text] [Related]
13. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
14. IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22.
Wu C; Wang Z; Zourelias L; Thakker H; Passineau MJ
Arthritis Res Ther; 2015 Aug; 17(1):198. PubMed ID: 26245278
[TBL] [Abstract][Full Text] [Related]
15. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nourishing Yin, strengthening Qi and activating blood decoction on Fas/FasL in salivary glands of NOD mice with Sjogren's syndrome and their mRNA expression].
Wu GL; Li TY; Lu WW; Yu GY; Fan YS
Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4148-51. PubMed ID: 24791507
[TBL] [Abstract][Full Text] [Related]
17. Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.
Kok MR; Yamano S; Lodde BM; Wang J; Couwenhoven RI; Yakar S; Voutetakis A; Leroith D; Schmidt M; Afione S; Pillemer SR; Tsutsui MT; Tak PP; Chiorini JA; Baum BJ
Hum Gene Ther; 2003 Nov; 14(17):1605-18. PubMed ID: 14633403
[TBL] [Abstract][Full Text] [Related]
18. Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome.
Xiao L; Ng TB; Feng YB; Yao T; Wong JH; Yao RM; Li L; Mo FZ; Xiao Y; Shaw PC; Li ZM; Sze SC; Zhang KY
Phytomedicine; 2011 Jan; 18(2-3):194-8. PubMed ID: 20655712
[TBL] [Abstract][Full Text] [Related]
19. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
20. Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome.
Tsubota K; Hirai S; King LS; Agre P; Ishida N
Lancet; 2001 Mar; 357(9257):688-9. PubMed ID: 11247557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
